SML3696

DHMEQ

≥98% (HPLC)

• Synonym(e): 2-Hydroxy-N-[2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide, DHM2EQ, Dehydroxymethylepoxyquinomicin, rel-2-Hydroxy-N-[(1R,2R,6R)-2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl]benzamide
• Empirische Formel (Hill-System): C₁₃H₁₁NO₅
• CAS-Nummer: 287194-38-1
• Molekulargewicht: 261.23
• MDL-Nummer: MFCD23135615
• UNSPSC-Code: 12352200

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 2 mg/mL, clear
• Lagertemp.: 2-8°C
• SMILES String: O[C@@H]1[C@@]2([H])[C@](C(C=C1NC(C3=C(C=CC=C3)O)=O)=O)([H])O2

Beschreibung

Biochem./physiol. Wirkung

Potent, selective, and irreversible inhibitor of NF-κB that covalently binds to a cysteine residue.



DHMEQ is a potent, selective, and irreversible inhibitor of NF-κB that covalently binds to a cysteine residue. It inhibits inflammatory cytokine expression in mice models. DHMEQ is a potent and non/low toxic in vivo anti-inflammatory agent effective in number of animal models.

Sicherheitshinweise

• Piktogramme: GHS07
• Signalwort: Warning
• H-Sätze: H302,H315,H317,H319,H335
• P-Sätze: P261 - P264 - P280 - P301 + P312 - P302 + P352 - P305 + P351 + P338
• Gefahreneinstufungen: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3
• Zielorgane: Respiratory system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable